1,5-Disubstituted indazol-3-ols with anti-inflammatory activity

Archiv der Pharmazie

Volumn 331, Issue 1, 1998, Pages 13-21

  Schindler, Rudolf ^a   Fleischhauer, Ilona ^a   Höfgen, Norbert ^a   Sauer, Wolfgang ^a   Egerland, Ute ^a   Poppe, Hildegard ^a   Heer, Sabine ^a   Szelenyi, Istvan ^a   Kutscher, Bernhard ^a   Engel, Jürgen ^a  

^a ASTA MEDICA AG   (Germany)

Author keywords

Antiinflammatory activity; Asthma; Indazole derivatives; Inhibitors of 5 lipoxygenase

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 5 METHOXY 1 [4 (2 QUINOLINYLMETHOXY)BENZYL] 1H INDAZOL 3 OL; INDAZOLE DERIVATIVE; LIPOXYGENASE; UNCLASSIFIED DRUG; ZILEUTON;

ANAPHYLAXIS; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; GUINEA PIG; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; TOPICAL DRUG ADMINISTRATION; TRACHEA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EOSINOPHILIA; GUINEA PIGS; INDAZOLES; MICE; TUMOR CELLS, CULTURED;

EID: 0031932357     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199801)331:1<13::AID-ARDP13>3.0.CO;2-M     Document Type: Article

References (15)

1. C.D.W. Brooks, J.B. Summers, J. Med. Chem. 1996, 39, 2629-2654.
2. Drugs Future 1996, 21, 771-772.
3. E. Israel, J. Am. Med. Ass. 1996, 275, 931-936.
4. R. Mueller-Peddinghaus, S. Raddatz, Drugs Future 1995, 20, 996-1000.
5. L. Baiocchi, G. Corsi, G. Palazzo, Synthesis 1978, 633-648.
6. K. Pfannstiel, J. Janecke, Ber. Dtsch. Chem. Ges. 1942, 75, 1096-1107.
7. T.R. Jones, L. Charette, D. Denis, Br. Pharmacol. 1988, 95, 309-321.
8. J. Bousquet, P. Chanez, J.Y. Lacoste, N. Engl. J. Med. 1990, 323, 1033-1039.
9. N. Chand, J.E. Harrison, S.M. Rooney, K.W. Nolan, C.L. DeVine, R.G. Jakubicki, J. Pillar, W. Diamantis, R.D. Sofia, Allergy 1993, 48, 624-626.
10. P.P. Bradley, D.A. Priebat, R.D. Christensen, G. Rothstein, J. Invest. Dermatol. 1982, 78, 206-209.
11. B. Kotyuk, A. Raychaudhuri, G. DiPasquale, Agents Actions 1993, 39, C 46-48.
12. R. Müller-Peddinghaus, C. Kohlsdorfer, P. Theisen-Popp, R. Fruchtmann, E. Perzborn, B. Beckermann, K. Bühner, H.J. Ahr, K.H. Mohrs, J. Pharmacol. Exp.Ther. 1993, 267, 51-57.
13. R.C. Murphy, W.R. Mattews in Methods in Enzymology (Ed.: S.P. Colowick, N.O. Kaplan), Academic Press, New York, 1982, 86, pp. 409-416.
14. D.C. Argentieri, D.M. Ritchie, M.P. Ferro, T. Kirchner, M.P. Wachter, D.W. Anderson, M.E. Rosenthale, R.J. Capetola, J. Pharm. Exp. Ther. 1994, 271, 1399-1408.
15. G.W. Carter, P.R. Young, D.H. Albert, J. Bouska, R. Dyer, R.L. Bell, J.B. Summers, D.W. Brooks, J. Pharm. Exp. Ther. 1991, 256, 929-937.